Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 4.


Szijgyarto, Zsolt, Flach, Koen D, Opdam, Mark, Palmieri, Carlo ORCID: 0000-0001-9496-2718, Linn, Sabine C, Wesseling, Jelle, Ali, Simak, Bliss, Judith M, Cheang, Maggie Chon U, Zwart, Wilbert
et al (show 1 more authors) (2019) Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)-PathIES. BREAST CANCER RESEARCH AND TREATMENT, 175 (1). 149 - 163.


Ruenraroengsak, Pakatip, Kiryushko, Darya, Theodorou, Ioannis G, Klosowski, Michal M, Taylor, Erik R, Niriella, Thisa, Palmieri, Carlo ORCID: 0000-0001-9496-2718, Yague, Ernesto, Ryan, Mary P, Coombes, R Charles
et al (show 2 more authors) (2019) Frizzled-7-targeted delivery of zinc oxide nanoparticles to drug-resistant breast cancer cells. NANOSCALE, 11 (27). 12858 - 12870.


Palmieri, Carlo ORCID: 0000-0001-9496-2718, Szydlo, Richard, Miller, Marie, Barker, Laura, Patel, Neva H, Sasano, Hironobu, Barwick, Tara, Tam, Henry, Hadjiminas, Dimitri, Lee, Jasmin
et al (show 4 more authors) (2017) IPET study: an FLT-PET window study to assess the activity of the steroid sulfatase inhibitor irosustat in early breast cancer. BREAST CANCER RESEARCH AND TREATMENT, 166 (2). 527 - 539.


Palmieri, Carlo ORCID: 0000-0001-9496-2718, Stein, Rob C, Liu, Xinxue, Hudson, Emma, Nicholas, Hanna, Sasano, Hironobu, Guestini, Fouzia, Holcombe, Chris, Barrett, Sophie, Kenny, Laura
et al (show 6 more authors) (2017) IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients. BREAST CANCER RESEARCH AND TREATMENT, 165 (2). 343 - 353.

This list was generated on Fri Nov 26 01:25:02 2021 GMT.